208 related articles for article (PubMed ID: 28837252)
1. Chromobox homolog 8 is a predictor of muscle invasive bladder cancer and promotes cell proliferation by repressing the p53 pathway.
Yuan GJ; Chen X; Lu J; Feng ZH; Chen SL; Chen RX; Wei WS; Zhou FJ; Xie D
Cancer Sci; 2017 Nov; 108(11):2166-2175. PubMed ID: 28837252
[TBL] [Abstract][Full Text] [Related]
2. Paradoxical role of CBX8 in proliferation and metastasis of colorectal cancer.
Tang J; Wang G; Zhang M; Li FY; Sang Y; Wang B; Hu K; Wu Y; Luo R; Liao D; Cao J; Wang X; Wang L; Zhang R; Zhang X; Deng WG; Xie D; Xu RH; Kang T
Oncotarget; 2014 Nov; 5(21):10778-90. PubMed ID: 25360999
[TBL] [Abstract][Full Text] [Related]
3. Increased Expression of Circular RNA circ_0005230 Indicates Dismal Prognosis in Breast Cancer and Regulates Cell Proliferation and Invasion via miR-618/ CBX8 Signal Pathway.
Xu Y; Yao Y; Leng K; Ji D; Qu L; Liu Y; Cui Y
Cell Physiol Biochem; 2018; 51(4):1710-1722. PubMed ID: 30504704
[TBL] [Abstract][Full Text] [Related]
4. CBX8 promotes lung adenocarcinoma growth and metastasis through transcriptional repression of CDKN2C and SCEL.
Chen H; Su Y; Yang L; Xi L; Li X; Lan B; Liu M; Xuan C
J Cell Physiol; 2023 Nov; 238(11):2710-2723. PubMed ID: 37733753
[TBL] [Abstract][Full Text] [Related]
5. Expression parameters of the polycomb group proteins BMI1, SUZ12, RING1 and CBX7 in urothelial carcinoma of the bladder and their prognostic relevance.
Hinz S; Kempkensteffen C; Christoph F; Krause H; Schrader M; Schostak M; Miller K; Weikert S
Tumour Biol; 2008; 29(5):323-9. PubMed ID: 18984978
[TBL] [Abstract][Full Text] [Related]
6. CBX8, a novel DNA repair protein, promotes tumorigenesis in human esophageal carcinoma.
Xiao W; Ou C; Qin J; Xing F; Sun Y; Li Z; Qiu J
Int J Clin Exp Pathol; 2014; 7(8):4817-26. PubMed ID: 25197352
[TBL] [Abstract][Full Text] [Related]
7. IMP3 is a biomarker for non-muscle-invasive urothelial carcinoma of the bladder associated with an aggressive phenotype.
Yang F; Zhou Q; Meng L; Xing N
Medicine (Baltimore); 2019 Jul; 98(27):e16009. PubMed ID: 31277094
[TBL] [Abstract][Full Text] [Related]
8. CBX8 promotes tumorigenesis and confers radioresistance in esophageal squamous cell carcinoma cells through targeting APAF1.
Zhang Y; Chen H; Zhu H; Sun X
Gene; 2019 Aug; 711():143949. PubMed ID: 31255735
[TBL] [Abstract][Full Text] [Related]
9. KPNA2 interaction with CBX8 contributes to the development and progression of bladder cancer by mediating the PRDM1/c-FOS pathway.
Zeng F; Luo L; Li D; Guo J; Guo M
J Transl Med; 2021 Mar; 19(1):112. PubMed ID: 33731128
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of Bmi1 inhibits bladder cancer cell growth both in vitro and in vivo by blocking cell cycle at G1 phase and inducing apoptosis.
Luo HB; Li B; Yuan WG; Xu CR
J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):730-735. PubMed ID: 26489630
[TBL] [Abstract][Full Text] [Related]
11. Insulin-Like Growth Factor-1 Modulates Polycomb Cbx8 Expression and Inhibits Colon Cancer Cell Apoptosis.
Yang S; Liu W; Li M; Wen J; Zhu M; Xu S
Cell Biochem Biophys; 2015 Apr; 71(3):1503-7. PubMed ID: 25398592
[TBL] [Abstract][Full Text] [Related]
12. High expression of Notch ligand Jagged2 is associated with the metastasis and recurrence in urothelial carcinoma of bladder.
Li W; Liu M; Feng Y; Huang YF; Xu YF; Che JP; Wang GC; Zheng JH
Int J Clin Exp Pathol; 2013; 6(11):2430-40. PubMed ID: 24228105
[TBL] [Abstract][Full Text] [Related]
13. hsa‑miR‑429 targets CBX8 to promote cell apoptosis in diffuse large B‑cell lymphoma.
Liang Y; Yu ZJ; Liu M; Liu HM; Zhang JZ; Xiong T; Tang YY; Huang ZP
Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34651663
[TBL] [Abstract][Full Text] [Related]
14. Regularly methylated novel pro-apoptotic genes associated with recurrence in transitional cell carcinoma of the bladder.
Christoph F; Weikert S; Kempkensteffen C; Krause H; Schostak M; Miller K; Schrader M
Int J Cancer; 2006 Sep; 119(6):1396-402. PubMed ID: 16642478
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA MIR31HG and its splice variants regulate proliferation and migration: prognostic implications for muscle invasive bladder cancer.
Wu S; Nitschke K; Worst TS; Fierek A; Weis CA; Eckstein M; Porubsky S; Kriegmair M; Erben P
J Exp Clin Cancer Res; 2020 Dec; 39(1):288. PubMed ID: 33334367
[TBL] [Abstract][Full Text] [Related]
16. Chromobox homolog 8 (CBX8) Interacts with Y-Box binding protein 1 (YBX1) to promote cellular proliferation in hepatocellular carcinoma cells.
Xiao L; Zhou Z; Li W; Peng J; Sun Q; Zhu H; Song Y; Hou JL; Sun J; Cao HC; Zhongyi D; Wu D; Liu L
Aging (Albany NY); 2019 Sep; 11(17):7123-7149. PubMed ID: 31495785
[TBL] [Abstract][Full Text] [Related]
17. CDKN2A as transcriptomic marker for muscle-invasive bladder cancer risk stratification and therapy decision-making.
Worst TS; Weis CA; Stöhr R; Bertz S; Eckstein M; Otto W; Breyer J; Hartmann A; Bolenz C; Wirtz RM; Erben P
Sci Rep; 2018 Sep; 8(1):14383. PubMed ID: 30258198
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of long non-coding RNA TUG1 predicts poor prognosis and promotes cancer cell proliferation and migration in high-grade muscle-invasive bladder cancer.
Iliev R; Kleinova R; Juracek J; Dolezel J; Ozanova Z; Fedorko M; Pacik D; Svoboda M; Stanik M; Slaby O
Tumour Biol; 2016 Oct; 37(10):13385-13390. PubMed ID: 27460088
[TBL] [Abstract][Full Text] [Related]
19. The co-expression of CBX8 and PD-L1 and prognostic value in cervical cancer.
Zhou H; Li A; Li C; Wu M; Jin D; Shui M
Medicine (Baltimore); 2021 Aug; 100(34):e27056. PubMed ID: 34449496
[TBL] [Abstract][Full Text] [Related]
20. Identification of extracellular vesicle-borne periostin as a feature of muscle-invasive bladder cancer.
Silvers CR; Liu YR; Wu CH; Miyamoto H; Messing EM; Lee YF
Oncotarget; 2016 Apr; 7(17):23335-45. PubMed ID: 26981774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
